Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Oncol Pharm Pract ; 28(1): 39-48, 2022 Jan.
Article in English | MEDLINE | ID: mdl-33565361

ABSTRACT

BACKGROUND: Our study aimed to investigate the association between multidrug resistance (MDR1) C1236T, C3435T and G2677T/A polymorphisms and the response to imatinib (IM) in chronic myeloid leukemia (CML). MATERIALS AND METHODS: An electronic databases in PubMed, Embase, Web of Knowledge, Scopus and Cochrane were searched using combinations of keywords relating to MDR1 polymorphisms and the response to IM in CML. Studies retrieved from database searches were screened using strict inclusion and exclusion criteria. RESULTS: In total, 37 studies were initially identified, and 17 studies, involving 4494 CML patients, were eventually included in this meta-analysis.Results of our study revealed significant association between MDR1 G2677T/A and C3435T polymorphisms and response to IM in Caucasian population under recessive model (T or A vs G; OR = 1.43,95%CI [1;06-1.93]; T vs C;OR = 1.13; 95%IC [0.79; 1.63]), dominant (T or A vs G; OR = 0.94; 95%CI [0.74-1.21]; T vs C; OR = 1.49; 95%CI [1.02-2.17]) and heterozygous models (T or A vs G; OR = 0.83; 95%CI [0.64; 1.09]; T vs C; OR = 1.52; 95%CI [1.01-2.28]); respectively. However, never significative association was found between IM response and the MDR1 C1236T polymorphism (OR = 1.25; 95%CI [0.46; 3.33]). CONCLUSION: The MDR1 G2677T/A and C3435T polymorphisms might be a risk factor for resistance to IM in Caucasian CML patients.


Subject(s)
Imatinib Mesylate , Leukemia, Myelogenous, Chronic, BCR-ABL Positive , Polymorphism, Single Nucleotide , ATP Binding Cassette Transporter, Subfamily B/genetics , Genotype , Humans , Imatinib Mesylate/therapeutic use , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics
2.
Andrologia ; 49(1)2017 Feb.
Article in English | MEDLINE | ID: mdl-27135983

ABSTRACT

The aim of the study was to evaluate the antioxidant potential of hydroxytyrosol (HT) on human sperm quality during incubation in vitro. Semen samples collected from men attending the Laboratory of Histology-Embryology of Sfax Faculty of Medicine (Tunisia) for infertility investigations were evaluated for initial sperm parameters. Only normal selected ejaculates (n = 15) were centrifuged and incubated further with or without HT (200ug ml-1 ) at room temperature for 45 min. After incubation, sperm motility and viability, DNA oxidation and reactive oxygen species (ROS) production were assessed. The results showed that centrifugation significantly influenced sperm motility and viability. The supplementation of HT in incubating media improved (P = 0.01) significantly sperm viability and decreased sperm DNA oxidation (P < 0.001) and ROS levels (P = 0.03) following centrifugation. It can be concluded that supplementation of HT might be helpful to maintain the human spermatozoon after centrifugation.


Subject(s)
Antioxidants/pharmacology , Oxidative Stress/drug effects , Phenylethyl Alcohol/analogs & derivatives , Spermatozoa/drug effects , Adult , Humans , Male , Middle Aged , Phenylethyl Alcohol/pharmacology , Reactive Oxygen Species/metabolism , Semen Analysis , Sperm Motility/drug effects , Spermatozoa/metabolism
3.
Transfus Clin Biol ; 23(2): 103-5, 2016 May.
Article in French | MEDLINE | ID: mdl-26826911

ABSTRACT

Alloimmunization against high-frequency erythrocyte antigens is a problematic situation in terms of laboratory diagnosis, transfusion and obstetrical management. We report the case of a pregnant woman alloimmunized against public Ag. We detail the difficulties of alloantibody (Ab) identification and transfusion management of the deliveries. A 29-year-old pregnant woman was hospitalized in gynecology and obstetrics departments at 36 weeks of gestation for assessment of hydrops fetalis. Antibody identification test revealed the presence of a pan-reactive antibody. Investigations realized in CNRGS (Paris) concluded in anti-GE2+anti-RH3+autoantibody. The red cell phenotype was GE: -2,3. A therapeutic interruption of the pregnancy was indicated. A program of autologous transfusion was organized with withdrawal of 2 units of blood. The 2nd pregnancy took place normally. Before delivery, an autologous blood reserve consisting of 2 red cell packs and 2 fresh frozen plasma was withdrawn and transfused after delivery. The management of anti-public alloimmunization poses several problems. The first one is of diagnostic nature with, on the one hand, the difficulty of Ab identification by the available red cell panels and, on the other hand, the possible presence of alloantibodies of transfusional or obstetric interest masked by anti-public Ab. The second is represented by transfusional care of these patients. In the absence of a national reserve of frozen rare blood, the autologous transfusion remains the only alternative. However, it can answer only a limited number of indications and only in case of moderate blood loss.


Subject(s)
Blood Group Antigens/immunology , Blood Group Incompatibility/diagnosis , Blood Transfusion, Autologous , Glycophorins/immunology , Hydrops Fetalis/etiology , Pregnancy Complications/diagnosis , Abortion, Therapeutic , Adult , Blood Group Incompatibility/blood , Blood Grouping and Crossmatching , Erythrocyte Transfusion , Female , Glycophorins/genetics , Humans , Isoantibodies/blood , Isoantibodies/immunology , Plasma , Pregnancy , Pregnancy Complications/immunology , Pregnancy Complications/therapy
4.
Transfus Clin Biol ; 19(6): 345-52, 2012 Dec.
Article in French | MEDLINE | ID: mdl-23103424

ABSTRACT

AIMS: To estimate the rate of red cell immunization in hemoglobinopathies. PATIENTS AND METHODS: Prospective study (1990-2009) about 84 patients: 44 homozygous sickle cell anemia, one heterozygous sickle cell anemia S/C, 30 thalassemia and nine sickle cell anemia-thalassemia. The mean age was 10.13 years (extremes: 1-45). The red cell units transfused were ABORH1 compatible, then RH-KELL phenotyped after 2006 and phenocompatible after alloimmunisation. The cross-match was realized using indirect antiglobuline test. Irregular red cell antibody screening was realized before every transfusional episode and the direct antiglobuline test was done when there was a poor transfusional efficiency. RESULTS: The number of red blood cells units transfused was 3545 (42.2/patient). The number of red cell antibody screening and the number of direct antiglobulin test were respectively 1474 (17.5/patient) and 272 (3.2/patient). Twenty-seven antibodies were identified (32.1%): 14 alloantibodies (16.6%, 16.6% in sickle cell disease, 16.6% in thalassemia, P=1), 16 antoantibodies (19.04%, 11.1% in sickle cell disease, 33.3% in thalassemia, P=0.018). There were three cases of association of allo- and autoantibodies. The most frequent alloantibodies were anti-RH3 and anti-KEL1 and were developed after transfusion of standard red cell units. There was no significant relation, neither between sex and risk of immunization, nor between the number of red cell units transfused and alloimmunization. On the other hand, there was a significant relation between autoimmunization and the number of red cell units transfused in thalassemia (P<0.001). CONCLUSION: This study proves the interest of using RH-KELL red cell units compatible in patients with hemoglobinopathies in order to reduce alloimmunisation rates.


Subject(s)
Anemia, Sickle Cell/immunology , Erythrocytes/immunology , Thalassemia/immunology , Adolescent , Adult , Anemia, Sickle Cell/therapy , Autoantibodies , Child , Child, Preschool , Erythrocyte Transfusion , Female , Humans , Infant , Isoantibodies/immunology , Male , Middle Aged , Prospective Studies , Thalassemia/therapy , Young Adult
5.
Transfus Clin Biol ; 19(2): 64-73, 2012 Apr.
Article in French | MEDLINE | ID: mdl-22475490

ABSTRACT

PURPOSE OF THE STUDY: To evaluate the prevalence of alloimmunization in women followed in an obstetrical environment in Tunisia, to identify the specificities of antibodies found and to determine factors that could influence the appearance of this immunization. METHODS: We proceeded to a retrospective analysis of search for irregular antibodies in women followed up in obstetrical environment over nine consecutive years (2000-2008). The panel was officially defined and produced by the Regional Centre for Blood Transfusion in Sfax (Tunisia). RESULTS: Overall 5369 women benefited from 6575 antibody testing (average: 1.22; extremes: 1-14). The results were positive for 278 women (5.17 %), allowing to identify 216 antibodies or associations of antibodies. Among identified antibodies, those immune were found in 198 women. The rate of alloimmunization was 3.68 % (198/5369). The majority of the antibodies found was anti-Rh1, isolated or associated with another antibody, in 84.3 % of the total immunized women. The immunization of women according to the number of gestations showed a significant increasing rate ranging from 2.34 % for a first gestation to 5.27 % for four gestations or more. In addition, a significant difference was also noted between the rate of immunization in women who had received anti-Rh1 immunoglobulin and those who had not. CONCLUSION: Anti-Rh1 immunization is the most frequent in the population of studied women. This could denote of an insufficiency in pregnancies follow-up and immunoprophylaxis protocols.


Subject(s)
Blood Group Antigens/immunology , Blood Group Incompatibility/epidemiology , Isoantibodies/blood , Pregnancy/immunology , Adult , Blood Group Incompatibility/therapy , Blood Transfusion/statistics & numerical data , Erythrocytes/immunology , Female , Fetal Blood/immunology , Hemagglutination Tests , Hemagglutinins/blood , Humans , Immunization , Isoantibodies/therapeutic use , Parity , Pregnancy Complications/epidemiology , Retrospective Studies , Rh-Hr Blood-Group System/immunology , Tunisia/epidemiology
6.
Arch Inst Pasteur Tunis ; 86(1-4): 69-74, 2009.
Article in English | MEDLINE | ID: mdl-20707222

ABSTRACT

The aim of the study was to assess hepatitis A virus (HAV) seroprevalence in blood donors from South Tunisia in two periods 2000 and 2007. Serum samples collected from 376 blood donors in each period aged 18 to 30 years from different regions of South Tunisia were analysed for anti-HAV IgG. The global seroprevalence of HAV infection was 85.9% in 2007 as compared with 94.9% in 2000. The seroprevalence in the 18-20 years age group was 91.9% in 2000 vs 80.6% in 2007, and increased to 99% in 2000 and 92% in 2007 in the subjects over 26. Taking account of geographic area, the HAV seroprevalence in Sfax city decreased from 88.9% in 2000 to 62.7% in 2007 (p < 0.001), but it is still approximatively the same in rural areas (98.4% and 96%) and in the governorates of South Tunisia (97.6% and 99.2%). In conclusion, the number of adults in the city of Sfax which are not immunized against HAV is increasing. Thus, adolescents and young adults are at risk to develop symptomatic and potentially severe hepatitis A.


Subject(s)
Blood Donors/statistics & numerical data , Endemic Diseases/statistics & numerical data , Hepatitis A/epidemiology , Rural Health/trends , Urban Health/trends , Adolescent , Adult , Age Distribution , Cross-Sectional Studies , Endemic Diseases/prevention & control , Female , Hepatitis A/blood , Hepatitis A/etiology , Hepatitis A/prevention & control , Hepatitis A virus/immunology , Humans , Logistic Models , Male , Multivariate Analysis , Population Surveillance , Residence Characteristics , Risk Factors , Seroepidemiologic Studies , Tunisia/epidemiology , Vaccination/statistics & numerical data
7.
Article in French | MEDLINE | ID: mdl-9231182

ABSTRACT

PURPOSE OF THE STUDY: Septic arthritis is frequent in Tunisia and is responsible for orthopedic sequela. The purpose of this study was to establish the indication and the viability of ultrasound scanning in the early diagnosis of septic arthritis. MATERIAL AND METHODS: 82 patients were explored by ultrasonography for suspected septic arthritis. Mean age was 7 years (range 2 months to 37 years). All sonographic studies were performed using a 7.5 MHZ transducer. 52 patients were surgically treated or had joint aspiration. Only 39 patients had septic arthritis. The hip and the knee were the most frequent localisation (respectively 20 and 12 cases). RESULTS: Statistical analysis showed that the ultrasound scanning in the diagnosis of joint effusion had a sensitivity of 93.4 per cent and a specificity of 100 per cent. Matter floating within the joint effusion was noted in 50 per cent of septic arthritis. These changes were not found in other arthritis. The thickness of synovialis and joint capsule was not specific of septic arthritis. In hip septic arthritis (51 per cent of localisation) the mean width of the anterior synovial recess was 11.7 mm (5-20 mm). In the asymptomatic opposite hip, the mean width was 3.6 mm (2.6-5 mm). Cortical irregularities had suggested osteomyelitis of femoral neck in osteoarthritis of the hip in 4 cases. Subperiosteal abscess of the femoral neck was directly visualized in another patient. DISCUSSION AND CONCLUSION: Our expense highlights that sonography may be a useful tool in the management of patient with suspect septic arthritis. Sonography allows early diagnosis of joint effusion with high accuracy. Hyperechoic or mixed aspects of the fluid joint suggest septic origin.


Subject(s)
Arthritis, Infectious/diagnostic imaging , Hip Joint , Knee Joint , Shoulder Joint , Adolescent , Adult , Arthritis, Infectious/microbiology , Arthritis, Infectious/surgery , Child , Child, Preschool , Female , Humans , Infant , Male , Prognosis , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...